Recalls and suspensions

Subscribe to TGA safety information
14 November 2019
Product defect correction – risk of delayed therapy due to potential battery issues
5 September 2019
Recall - potential toxicity (金 匮 肾 气 丸 - statement includes Chinese translation 中文翻译)
2 August 2019
Hazard alert – risk of breast implant-associated anaplastic large cell lymphoma in rare cases
30 July 2019
Product defect correction – potential for incorrect medicine in the pack

More safety information »

Safety information

Subscribe to TGA safety information
19 November 2019
Ying Da Wang tablets pose a serious risk to your health and should not be taken
18 November 2019
The list of current ARTG entries for breast implants has been updated
14 November 2019
De2Xy capsules pose a serious risk to your health and should not be taken
13 November 2019
Me2Shape capsules pose a serious risk to your health and should not be taken.

More safety information »

News

Subscribe to TGA latest news and updates
20 November 2019
TGA presentations from the 2019 BAA conference have been published
20 November 2019
Australian Public Assessment Report for Nivolumab
19 November 2019
Consumer Healthcare Products Australia to handle all medicine advertising pre-approval applications
19 November 2019
The TGA has joined the ICMRA and the WHO in a coordinated global approach to fighting antimicrobial resistance

More news »